Drugs Four Last Time Flashcards
fuck
Herpesvirus group and ones there is treatment for
- Herpes simplex
- Varicella zoster
- cytomegalovirus
- epstein barr (no treatment)
Acyclovir
Agent of choice for herpes symplex and varicella zoster virus functions to inhibit viral DNA poly and incorporate into strand of viral DNA blocking further growth through cell conversion into acyclo-GMP
Acyclovir absorption
Topical, oral, IV
Acyclovir ADR’s
None!
Acyclovir resistance (3)
- decreased production of thymidine kinase
- alteration of thymidine kinase
- alteration of viral DNA poly so its less sensitive to inhibition
Acyclinovir is not a…
…cure for the virus, it just decreases symptoms
Vlacyclovir
More popular prodrug form of acyclovir, approved for PO therapy in immunocompetent host
Vlacyclovir ADR
Immunocompromised patients experience thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS)
Famciclovir
-Same as acyclovir but used only for acute herpes zoster and herpes simplex genitalis
Penciclovir
Topical drug indicated for recurrent herpes labialis (cold sores) in immunocompetent adults caused by HSV1 and 2
Docosanol
OTC treatment for herpes labialis, inhibits fusion btwn plasma membrane and viral envelope increasing healing with first sign of coldsore
Ganciclovir
Synthetic antiviral agent with activity against cytomegaolvirus
CMV in immunocompromised patient (AIDS) leads to…
CMV retinitis and eventual blindness
Valganciclovir
Prodrug version of ganciclovir with PO formulation but same indications for CMV retinitis and prevention and results
Ganciclovir ADRs
serious ADRS such as granulocytopenia and thrombocytopenia and hsould be restricted to treat CMV in immunocompromised host
Cidofir
Alternate for ganciclovir requiring fewer IV infusions
Cidofir ADRs
- Nephrotoxicity
- Probenecid and IV hydration therapy with each dose
- granulocytopenia
Foscarnet
Alternative for ganciclovir for CMV retinitis, IV antiviral but does not cause granulocytopenia or thrombocytopenia
6 diff hepatitis viruses and do they become chronic
A B chronic (most common) C chronic (most common) D chronic E G
Hep C genotypes and their resistance
Genotype 1 - resistant, 75%
2-6 - susceptible, 25%
Direct acting antivriral drugs (DAAs)
Target specific steps in HCV replication without damage to healthy cells, often used in combination to decrease viral resistance
Categories of DAAs
1) NS3/4A protease inhibitors
2) NS5A inhibitors
3) NS5B nucleoside polymerase inhibitors (NPIs)
4) NS5B non nucleoside polymerase inhibitors (NNPIs)